Germany’s Digital Health Fast-Track Scheme: What Manufacturers Need To Know
Understanding the German reimbursement system is crucial for any medtech firm eyeing the European market, and healthtech innovators in particular may benefit from its fast-track digital health app scheme. But how does the scheme work, and who can apply?
You may also be interested in...
European countries should establish “implementation budgets” to fund innovative cancer therapies and leverage technologies such as AI in drug R&D to meet the rising demand for cancer care, pharmaceutical industry representatives say.
Diverse national market access pathways for digital health technologies in Europe can make reimbursement tricky to navigate for manufacturers. A report by trade body COCIR maps digital health reimbursement routes in six European countries.
There are fewer than a handful of prescription video game digital therapeutics with regulatory clearance, but gamification in patient care is proving its worth as a novel way of treating a range of conditions, from vision loss to dyslexia and ADHD. Now, the onus is on lawmakers and insurers to create a clear path towards reimbursement.